SYNGENE INTERNATIONAL LIMITED

SYNGENE INTERNATIONAL LIMITED is a factory (manufacturer and service provider).

Company Introduction:

Syngene International Limited is an integrated research, development, and manufacturing organization providing scientific services from early discovery to commercial supply. It partners with pharmaceutical, biotechnology, nutrition, animal health, and consumer product companies to accelerate their R&D programs. Syngene offers a comprehensive suite of services including discovery chemistry and biology, safety assessment, development, and manufacturing. Its operations are characterized by state-of-the-art research facilities, advanced laboratories, and manufacturing plants, indicating its role as a key player in the contract research and manufacturing services (CRAMS) sector.

SYNGENE INTERNATIONAL LIMITED primarily offers contract research, development, and manufacturing services to pharmaceutical, biotechnology, nutrition, animal health, and specialty chemical companies. Their offerings, which constitute their sales, include:

1. Discovery Services: This includes target identification and validation, lead generation and optimization, medicinal chemistry, in vitro and in vivo pharmacology, ADME (absorption, distribution, metabolism, excretion) studies, toxicology, and structural biology.

2. Development Services: Providing support for pre-clinical and clinical development, process development, analytical development, and formulation development for both small molecules and biologics.

3. Manufacturing Services: Offering cGMP (current Good Manufacturing Practice) manufacturing for clinical supplies and commercial production of small molecules, biologics, oligonucleotides, and antibody-drug conjugates (ADCs).

4. Biologics Services: Comprehensive solutions for biologics discovery, development, and manufacturing, covering cell line development, process development, and analytical characterization.

5. Oligonucleotide Synthesis: Specialized services for the synthesis and manufacturing of oligonucleotides.

6. Antibody Drug Conjugate (ADC) Development and Manufacturing: Integrated services for the development and production of ADCs.

7. Integrated Drug Discovery and Development Solutions: Providing end-to-end support across the entire drug discovery and development pipeline.